Skip to main content
. 2022 Aug 2:1–15. Online ahead of print. doi: 10.1007/s10238-022-00856-7

Fig. 5.

Fig. 5

Expression of surface antigens/antigen combinations in patients with higher- and lower-risk MDS. a Expression of surface antigens in patients with higher- and lower-risk MDS. b Expression of surface antigen combinations in patients with higher- and lower-risk MDS. (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)